Related Experiment Videos
[Ethical problems in the testing of new cytostatic agents]
MMW, Munchener Medizinische Wochenschrift
|April 16, 1982
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Phase I and pharmacokinetic study of CCI-779, a novel cytostatic cell-cycle inhibitor, in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology·2003
Use of and attitudes held towards unconventional medicine by patients in a department of internal medicine/oncology and haematology.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2000
[Drug therapy of chronic pain. A practical approach].
MMW Fortschritte der Medizin·2000
Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors. European Organization for Research and Treatment of Cancer Early Clinical Studies Group.
Clinical cancer research : an official journal of the American Association for Cancer Research·2000
Population pharmacokinetics/toxicodynamics (PK/TD) relationship of SAM486A in phase I studies in patients with advanced cancers.
Journal of clinical pharmacology·2000
Therapy for squamous-cell carcinoma of the anus in HIV-positive patients.
ESMO gastrointestinal oncology·2026
FOXA1 drives chemoresistance through activating Wnt pathway in small cell lung cancer.
Translational lung cancer research·2026
Targeting chemobrain: from experimental models to therapeutic discovery.
Drug discovery today·2026
Single-cell and bulk RNA-seq with machine learning reveals CCNB1/CDK1-mediated G2/M arrest as key anti-HCC mechanism of Fuzheng Xiaozheng Prescription.
Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Biocompatibility and Antifungal Effects of Chitosan Nanoparticles Loaded With Nystatin and Carvacrol Against Candida albicans.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·2026